Resources
The latest in from biologics discovery and development through to production and supply chain management.
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Biologics Analysis
Overcoming the Hurdles: Navigating the Challenges of Bioconjugate Development
Bioconjugate development, exemplified by ADCs such as T-DM1 and Mylotarg, tackles issues like stability and specificity, benefiting from innovative solutions and services to enhance therapeutic precision in biologics.
Biologics Analysis
Biologics Market Trends and Predictions: New Horizons Beckon
Here, we outline some of the main trends anticipated in market growth and development for biologics in the next few years. The global biologics market is predicted to exceed $600bn by 2032, driven by demand for personalised treatments for chronic diseases.
Biologics Analysis
Mass Spectrometry: Shortening Time Scales and Progressing Towards Automation
Discover the top bioanalysis presentations from Biologics UK 2022.
Biologics Analysis
Turbocharging Potency Assays – Challenges and Opportunities from Multispecific Drug Modalities
The development of multispecific drugs is an inherently complex and challenging process. Barbara Hebeis of AstraZeneca talks us through challenges surrounding the development of appropriate potency assays, and the opportunities the field offers.
Biologics Analysis
The Black Box Effect - How Can AI and ML Provide Transparent Insights for Drug Discovery?
We interview Martin Akerman, Chief Technology Officer and Co-Founder at Envisagenics to find out about machine learning for drug target discovery in RNA.
Biologics Analysis
Nature Announces Top 10 R&D Institutes
The 2021 report is in, but who made the cut?
Biologics Analysis
The Countdown Begins: How ADCs will Become the Next Generation of Biologics Therapeutics
Key opinion leaders from AbbVie, Ambrx Inc, and Antikor Biopharma talk about the cutting-edge technology’s promise for better therapeutic index.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things biologics